Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

II.a

Left ventricular dysfunction/failure

De novo chronic, progressive or acute LV dysfunction/failure. May result from myocarditis or eosinophilic myocarditis. May cause congestive heart failure and/or pulmonary edema (see under II). Hypertension may be present. Symptoms range from worsening of preexisting LVF to acute cardiogenic pulmonary edema, shock or cardiopulmonary arrest. See also pulmonary edema under IId, and XIId, XIIf. Review at PMID 10193711, 16808550, 18083403, 21930637

Publications

Hayek ER, Speakman E, Rehmus E

Acute doxorubicin cardiotoxicity.

The New England journal of medicine 2005 Jun 09;352;2456-7 — 2005 Jun 09 — 2456-7

Singal PK, Iliskovic N

Doxorubicin-induced cardiomyopathy.

The New England journal of medicine 1998 Sep 24;339;900-5 — 1998 Sep 24 — 900-5

Bristow MR, Mason JW, Billingham ME, Daniels JR

Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.

Annals of internal medicine 1978 Feb;88;168-75 — 1978 Feb — 168-75

Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, Muggia FM

Risk factors for doxorubicin-induced congestive heart failure.

Annals of internal medicine 1979 Nov;91;710-7 — 1979 Nov — 710-7